Assessing the Team SA Instrument in Measuring the Effectiveness of Communication Across Disciplines During ICU Rounds

NCT ID: NCT01856608

Last Updated: 2014-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assessing the utility of the Team SA instrument in measuring the effectiveness of communication across disciplines during ICU rounds.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multidisciplinary rounds are events that occur daily in Intensive care units. During these events, practitioners from multiple disciplines meet at a pre-specified time to discuss current medical condition and plans of care. At the conclusion of these discussions, all practitioners are expected to understand the plan of care well enough to execute defined tasks, but also coordinate as circumstances change. In order to coordinate under changing circumstances practitioners must have a broader understanding of the current state of the patient and how likely certain deteriorations are. This synthetic understanding of patient risks across multi-provider groups has been described as anticipatory team situational awareness (Team SA). One instrument has been validated in the ICU as feasible and informative. This Team SA survey successfully identified that the time spent in "training" discussions improved Team SA across physician groups. The investigators' goal is to implement this survey across the investigators' medical ICU service to obtain a baseline estimate of how effective current communication patterns are for achieving concordant Team SA. If gaps in communication are encountered future interventions will be developed

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Personal Communication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nurses, primary clinicians (resident or NP) and Critical Care physicians (Staff or Fellow in Critical Care Medicine) will be approached for interview. All subjects will be approached individually and asked to participate outside of the presence of the other potential study subjects.

Exclusion Criteria

* N/A
Minimum Eligible Age

17 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Naeem Ali, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Naeem Ali, MD

Associate Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Naeem Ali, MD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Davis Heart and Lung Research Institute 473 w. 12TH aVE

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2012B0233

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.